UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
Breaking
MHRA approves new biosimilar●AstraZeneca Q1 results exceed forecast●NICE updates TA guidance for oncology●Roche launches Phase III rare disease trial●FDA grants breakthrough therapy designation●UK Biobank releases genomic dataset●GSK acquires clinical-stage biotech firm●EMA recommends novel gene therapy●MHRA approves new biosimilar●AstraZeneca Q1 results exceed forecast●NICE updates TA guidance for oncology●Roche launches Phase III rare disease trial●FDA grants breakthrough therapy designation●UK Biobank releases genomic dataset●GSK acquires clinical-stage biotech firm●EMA recommends novel gene therapy●
UK sets pathway for in vivo CRISPR gene editing trials
Clinical Trials

UK sets pathway for in vivo CRISPR gene editing trials

The UK is advancing in vivo CRISPR gene editing beyond ex vivo models. Explore regulatory signals, lipid nanoparticle delivery, and NHS reimbursement challenges.

Editorial|29 June 2026
Microbiome on a chip could cut drug trial failures
Clinical Trials

Microbiome on a chip could cut drug trial failures

Editorial·17 June 2026
UK Clinical Trial Reforms 2026: Accelerating Approvals
Clinical Trials

UK Clinical Trial Reforms 2026: Accelerating Approvals

Editorial·10 June 2026
NHS expands abiraterone access for high-risk prostate
Cancer

NHS expands abiraterone access for high-risk prostate

Editorial·4 March 2026

Latest Research & Insights

Expert analysis from pharmaceutical industry leaders

View All Articles→
Liquid biopsies could reshape NHS cancer screening in 2026
Research

Liquid biopsies could reshape NHS cancer screening in 2026

Liquid biopsies NHS pilot tests multi-cancer early detection to reshape screening pathways and achieve 75% Stage I-II cancer diagnosis by 2028.

Editorial·15 June 2026
Personalised medicines: the new frontier, the rise of CRISPR-based therapies in oncology
Research

Personalised medicines: the new frontier, the rise of CRISPR-based therapies in oncology

Editorial · 5 January 2026
The Role of Cathepsin B (CTSB) in Immune Response Studies
Research

The Role of Cathepsin B (CTSB) in Immune Response Studies

Editorial · 2 December 2025
Stem Cell Therapy for Type 1 Diabetes: Toward a Functional Cure
Research

Stem Cell Therapy for Type 1 Diabetes: Toward a Functional Cure

Editorial · 2 December 2025
Sponsored Content
AMGEN
Bayer
Axxa
Fujifilm
Vicks
Paid Partnership
AdvertisementSalamanca

Popular Categories

Explore our pharmaceutical industry directory

Browse All Categories→
Biotechnology
Clinical Research
Contract Manufacturing
Medical Devices, Diagnostics & Equipment
Pharmaceutical Companies
Consulting, Advisory & MedComms
AdvertisementSoho London

Pharma Journal

Your Trusted Pharmaceutical Insights

AdvertisementTeksyte LTD
📧

Get Weekly Pharma Insights

Join 2,500+ pharmaceutical professionals receiving expert analysis, regulatory updates, and industry news every Friday.

No spam. Unsubscribe anytime. We respect your privacy.

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy